The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review

Health Technol Assess. 2001;5(19):1-61. doi: 10.3310/hta5190.

Authors

J Chilcott¹, J Wight, M Lloyd Jones, P Tappenden

Affiliation

¹ University of Sheffield School of Health and Related Research, UK.

PMID: 11701097
DOI: 10.3310/hta5190

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review
Systematic Review

MeSH terms

Cost-Benefit Analysis
Diabetes Mellitus, Type 2 / drug therapy*
Drug Therapy, Combination
Humans
Hypoglycemic Agents / economics
Hypoglycemic Agents / therapeutic use*
Pioglitazone
Thiazoles / economics
Thiazoles / therapeutic use*
Thiazolidinediones*

Substances

Hypoglycemic Agents
Thiazoles
Thiazolidinediones
Pioglitazone